Surgical management of a locally advanced jejunal stromal tumor: A case report of a challenging condition
- PMID: 38086132
- PMCID: PMC10758957
- DOI: 10.1016/j.ijscr.2023.109155
Surgical management of a locally advanced jejunal stromal tumor: A case report of a challenging condition
Abstract
Introduction and importance: Locally advanced jejunal stromal tumors stand as a captivating and relatively rare entity, garnering attention for several reasons. Their inaccessible location by conventional endoscopy poses a diagnostic challenge. Further, treatment decisions necessitate a multidisciplinary approach, compounded by the absence of high-level evidence studies.
Case presentation: A 54-year-old patient was admitted to our surgical department with abdominal pain and chronic anemia. Abdominal CT imaging confirmed the presence of a non-metastatic sizable jejunal tumor. The patient underwent laparotomy, revealing a locally advanced jejunal tumor contracting the ileum and the ascending colon. A monobloc oncological resection was performed, followed by the restoration of digestive continuity. Anatomopathological analysis delineated a locally advanced Stromal Tumor with a high risk of recurrence. The patient underwent a course of tyrosine kinase inhibitors for 3 years, with no reported recurrence during the subsequent 3-year follow-up.
Discussion: Locally advanced jejunal stromal tumors are rare. Most patients present with unspecific symptoms. Diagnosis remains challenging due to their intricate anatomical location. Decisions regarding management must be deliberated within a multidisciplinary framework, tailored to each patient's unique characteristics. While combined therapeutic modalities have demonstrated efficacy in recent studies, prudence is advised given the heightened incidence of both short and long-term complications.
Conclusion: In the absence of randomized controlled trials, the management of locally advanced jejunal stromal tumors underscores the imperative of multidisciplinary collaboration in treatment deliberations. A wide, sometimes mutilating excision is only permissible if it is complete.
Keywords: Case report; Gastrointestinal stromal tumors; Jejunal neoplasms; Locally advanced; Protein kinase inhibitors.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of interest statement Nothing to declare.
Figures



References
-
- Nagaraj S.S., Deivasigamani S., Aruni A., Kumar H., Sachan A., Samanta J., Bal A. Diagnostic and therapeutic challenges in the management of acute massive overt bleeding of jejunal gastrointestinal stromal Tumours: case series. J. Gastrointest. Canc. 2023;54:316–322. doi: 10.1007/s12029-021-00650-w. - DOI - PubMed
-
- Agha R.A., Franchi T., Sohrabi C., Mathew G., Kerwan A., Thoma A., Beamish A.J., Noureldin A., Rao A., Vasudevan B., Challacombe B., Perakath B., Kirshtein B., Ekser B., Pramesh C.S., Laskin D.M., Machado-Aranda D., Miguel D., Pagano D., Millham F.H., Roy G., Kadioglu H., Nixon I.J., Mukherjee I., McCaul J.A., Chi-Yong Ngu J., Albrecht J., Rivas J.G., Raveendran K., Derbyshire L., Ather M.H., Thorat M.A., Valmasoni M., Bashashati M., Chalkoo M., Teo N.Z., Raison N., Muensterer O.J., Bradley P.J., Goel P., Pai P.S., Afifi R.Y., Rosin R.D., Coppola R., Klappenbach R., Wynn R., De Wilde R.L., Surani S., Giordano S., Massarut S., Raja S.G., Basu S., Enam S.A., Manning T.G., Cross T., Karanth V.K.L., Kasivisvanathan V., Mei Z., The S.C.A.R.E. Guideline: updating consensus surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2020;84(2020):226–230. doi: 10.1016/j.ijsu.2020.10.034. - DOI - PubMed
-
- Casali P.G., Blay J.Y., Abecassis N., Bajpai J., Bauer S., Biagini R., Bielack S., Bonvalot S., Boukovinas I., Bovee J.V.M.G., Boye K., Brodowicz T., Buonadonna A., De Álava E., Dei Tos A.P., Del Muro X.G., Dufresne A., Eriksson M., Fedenko A., Ferraresi V., Ferrari A., Frezza A.M., Gasperoni S., Gelderblom H., Gouin F., Grignani G., Haas R., Hassan A.B., Hindi N., Hohenberger P., Joensuu H., Jones R.L., Jungels C., Jutte P., Kasper B., Kawai A., Kopeckova K., Krákorová D.A., Le Cesne A., Le Grange F., Legius E., Leithner A., Lopez-Pousa A., Martin-Broto J., Merimsky O., Messiou C., Miah A.B., Mir O., Montemurro M., Morosi C., Palmerini E., Pantaleo M.A., Piana R., Piperno-Neumann S., Reichardt P., Rutkowski P., Safwat A.A., Sangalli C., Sbaraglia M., Scheipl S., Schöffski P., Sleijfer S., Strauss D., Strauss S.J., Hall K.S., Trama A., Unk M., van de Sande M.A.J., van der Graaf W.T.A., van Houdt W.J., Frebourg T., Gronchi A., Stacchiotti S., ESMO Guidelines Committee, EURACAN and GENTURIS. Electronic address: clinicalguidelines@esmo.org Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2022;vol. 33:20–33. doi: 10.1016/j.annonc.2021.09.005. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources